|
시장보고서
상품코드
1941468
누트로픽 시장 규모, 점유율, 동향 분석 보고서 : 형태별, 유통 채널별, 지역별, 부문별 예측(2026-2033년)Nootropics Market Size, Share & Trends Analysis Report By Form, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033 |
||||||
누트로픽 시장 요약
세계의 누트로픽 시장 규모는 2025년에 54억 5,000만 달러로 평가되며, 2033년까지 114억 8,000만 달러에 달할 것으로 예측됩니다.
2026-2033년 연평균 9.1%의 성장률을 보일 것으로 예측됩니다. 기술 발전과 분야의 현대화로 인해 예측 기간 중 업계는 급속한 확장을 이룰 것으로 예측됩니다.
예측 기간 중 다양한 헬스케어 및 웰니스 제품에 대한 소비자 지출 증가는 업계 성장을 가속할 것으로 예측됩니다. 또한 이러한 제품의 비용 효율성과 접근 용이성은 소비자의 제품 수요를 더욱 증가시킬 것으로 예측됩니다.
전인적 건강에 대한 관심이 높아짐에 따라 천연 유래 및 식물 기반 누트로픽 의약품에 대한 수요가 증가하고 있습니다. 이 화합물들은 식물에서 추출한 것으로, 자연스럽고 지속가능하며 윤리적인 웰빙 관행에 부합하므로 권장됩니다. 전인적 건강 개념에 따라 몸과 마음의 균형을 도모하고 인지 능력을 향상시키는 수단으로 인식되고 있습니다. 이 시장의 급격한 성장은 건강과 웰빙에 대한 소비자의 관심이 높아졌기 때문입니다. 대학 진학자 증가와 낮은 실업률로 인해 첨단 자격을 요구하는 노동력 시장에서 미래의 후보자들은 경쟁 우위를 확보하고 성과를 향상시킬 수 있는 자연스러운 방법을 모색하고 있습니다.
학업 및 직업적 우위를 위해 건강한 소비자들 사이에서 인지 기능 향상에 대한 관심이 높아지면서 향후 6년간 향정신성 의약품에 대한 수요가 증가할 것으로 예측됩니다. 또한 운동선수, 스포츠 전문가 및 자기계발을 목적으로 하는 소비자층에서 이 제품의 사용 확대는 예측 기간 중 시장에 긍정적인 영향을 미칠 것으로 예측됩니다.
고령화 인구 증가와 더불어 치매를 비롯한 각종 뇌 관련 질환 및 관절염 등의 문제 발생률 증가로 인해 누누이 지적 약물의 필요성이 높아지고 있습니다. 또한 이 제품들은 과잉행동장애, 파킨슨병 등 다른 인지기능 장애 및 노화 관련 질환의 치료에도 사용되고 있습니다. 전 세계 많은 소비자들이 우울증과 기타 기분 및 정서 장애로 고통 받고 있습니다. 따라서 기분 개선제에 대한 수요 증가는 향후 6년간 업계 성장을 가속할 것으로 예측됩니다.
각 제조업체들은 증가하는 누트로픽 수요에 대응하기 위해 연구개발, 신제품 출시, 품질관리, 비건 및 식물 유래 옵션, 다양한 틈새 시장을 위한 전문 제품 제공에 집중하고 있습니다. 예를 들어 2025년 8월, 구 임팩트 커피(Impact Coffee)의 자회사인 언컨폼(Unconform)은 향정신성 약물 강화 콜드브루 RTD 커피 라인을 발표했습니다. 이는 일반적인 카페인의 부작용 없이 정신의 명료함, 인지 기능의 연장, 소화기 및 면역 체계의 건강을 개선하는 것을 목표로 합니다. 250ml 캔은 플랫화이트(아슈와간다, 은행잎 추출물, 비타민B12 함유), 솔트 카라멜라떼(이눌린, 강황 함유), 모카(니아신, 비오틴 함유) 등 3가지 맛으로 출시되었습니다. 각 250ml 캔의 가격은 2.50파운드입니다. 또한 언컨폼에서는 면역력 향상, 정신의 명료성 향상, 장내 환경 개선, 미용 효과를 목적으로 한 무향료 유형의 '스마트 스틱'도 제공합니다. 10봉지 한 상자에 7.99파운드(약 1,300원)입니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 개요
제3장 누트로픽 시장 변수, 동향, 범위
제4장 소비자 행동 분석
제5장 누트로픽 시장 : 형태별 추정·동향 분석
제6장 누트로픽 시장 : 유통 채널별 추정·동향 분석
제7장 누트로픽 시장 : 지역별 추정·동향 분석
제8장 경쟁 분석
KSA 26.03.12Nootropics Market Summary
The global nootropics market size was valued at USD 5.45 billion in 2025 and is anticipated to reach USD 11.48 billion by 2033, growing at a CAGR of 9.1% from 2026 to 2033. The industry is expected to expand at a rapid pace over the forecast period on account of technological advancements as well as modernization in the field.
Rising consumer spending on various healthcare as well as wellness products is expected to fuel industry growth over the forecast period. In addition, cost-effectiveness as well as easy accessibility to these products are further expected to boost product needs among consumers.
The demand for natural and plant-based nootropics has increased with growing interest in holistic health. These compounds are recommended because they are sourced from plants and are in line with natural, sustainable, and ethical wellness practices. In keeping with the holistic health concept, they are viewed as a means of improving cognitive performance while encouraging balance between the mind and body. This market surge is a result of the rising consumer focus on health and wellness. With the increasing number of students attending college as well as a workforce that demands better qualifications due to the low unemployment rate, prospective candidates have been seeking natural ways to gain a competitive advantage and improve their performance.
The rising trend of cognitive enhancement among healthy consumers for academic and professional advantage is expected to fuel the need for nootropics over the next six years. In addition, the growing use of the product among athletes and sports professionals, as well as among consumers for personal improvement, will have a positive impact on the market over the forecast period.
The growing geriatric population, coupled with the rising occurrence of various brain-related diseases, including dementia and other issues such as arthritis, has increased the need for nootropics. Moreover, these products are employed for the treatment of other cognitive and age-related disorders, including hyperactivity, as well as Parkinson's disease. Numerous consumers across the globe have been undergoing depression as well as other mood and emotional disorders. Thus, rising demand for mood enhancers is also expected to stimulate industry growth over the next six years.
Manufacturers are responding to the rising demand for nootropics by focusing on research and development, as well as new product launches, quality control, vegan and plant-based options, and specialized products for various niches. For instance, in August 2025, Unconform, formerly Impact Coffee, launched a nootropic-enhanced cold brew RTD coffee line designed to improve mental clarity, cognitive longevity, digestive, and immune health without typical caffeine side effects. The 250ml cans come in three flavors: Flat White (with Ashwagandha, Ginkgo Biloba & Vitamin B12), Salted Caramel Latte (with Inulin and Turmeric), and Mocha (with Niacin & Biotin), priced at £2.50 each. Additionally, Unconform offers Smart Sticks-neutral-flavored sachets that boost immunity, mental clarity, gut health, or beauty, priced at £7.99 for a box of 10 sachets.
Global Nootropics Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global nootropics market report on the basis of form, distribution channel, and region:
- Form Outlook (Revenue, USD Million, 2021 - 2033)
- Capsules/Tablets
- Powder
- Drinks
- Others
- Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
- Offline
- Online
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia & New Zealand
- South Korea
- Central & South America
- Brazil
- Middle East & Africa
- UAE
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Products & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Product Outlook
- 2.3. Distribution Channel Outlook
- 2.4. Regional Outlook
Chapter 3. Nootropics Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.2. Industry Value Chain Analysis
- 3.2.1. Sales/Retail Channel Analysis
- 3.2.2. Profit Margin Analysis
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint Analysis
- 3.3.3. Market Opportunities
- 3.3.4. Market Challenges
- 3.4. Industry Analysis - Porter's Five Forces Analysis
- 3.5. Market Entry Strategies
Chapter 4. Consumer Behavior Analysis
- 4.1. Demographics Analysis
- 4.2. Consumer Trends and Preferences
- 4.3. Factors Affecting Buying Decision
- 4.4. Consumer Product Adoption
- 4.5. Key Observations & Findings
Chapter 5. Nootropics Market: Form Estimates & Trend Analysis
- 5.1. Form Movement Analysis & Market Share, 2025 & 2033
- 5.2. Capsules/Tablets
- 5.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.3. Powder
- 5.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.4. Drinks
- 5.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 5.5. Others
- 5.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
Chapter 6. Nootropics Market: Distribution Channel Range Estimates & Trend Analysis
- 6.1. Distribution Channel Movement Analysis & Market Share, 2025 & 2033
- 6.2. Offline
- 6.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 6.3. Online
- 6.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
Chapter 7. Nootropics Market: Regional Estimates & Trend Analysis
- 7.1. Regional Movement Analysis & Market Share, 2025 & 2033
- 7.2. North America
- 7.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.2.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.2.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.2.4. U.S.
- 7.2.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.2.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.2.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.2.5. Canada
- 7.2.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.2.5.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.2.5.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.2.6. Mexico
- 7.2.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.2.6.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.2.6.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.3. Europe
- 7.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.3.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.3.4. Germany
- 7.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.3.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.3.5. U.K.
- 7.3.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.5.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.3.5.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.3.6. France
- 7.3.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.6.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.3.6.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.3.7. Italy
- 7.3.7.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.7.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.3.7.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.3.8. Spain
- 7.3.8.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.3.8.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.3.8.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.4.4. China
- 7.4.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.4.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.4.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.4.5. India
- 7.4.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.4.5.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.4.5.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.4.6. Japan
- 7.4.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.4.6.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.4.6.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.4.7. South Korea
- 7.4.7.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.4.7.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.4.7.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.4.8. Australia & New Zealand
- 7.4.8.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.4.8.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.4.8.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.5. Central & South America
- 7.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.5.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.5.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.5.4. Brazil
- 7.5.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.5.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.5.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.6. Middle East & Africa
- 7.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.6.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.6.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
- 7.6.4. UAE
- 7.6.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
- 7.6.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
- 7.6.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
Chapter 8. Competitive Analysis
- 8.1. Recent developments & impact analysis, by key market participants
- 8.2. Company Categorization
- 8.3. Participant's Overview
- 8.4. Financial Performance
- 8.5. Product Benchmarking
- 8.6. Company Market Share Analysis, 2025 (%)
- 8.7. Company Heat Map Analysis
- 8.8. Strategy Mapping
- 8.9. List of key companies analyzed in this section include:
- 8.9.1. Onnit Labs, Inc.
- 8.9.1.1. Company Overview
- 8.9.1.2. Financial Performance
- 8.9.1.3. Product Benchmarking
- 8.9.1.4. Strategic Initiatives
- 8.9.2. Reckitt Benckiser Group PLC
- 8.9.2.1. Company Overview
- 8.9.2.2. Financial Performance
- 8.9.2.3. Product Benchmarking
- 8.9.2.4. Strategic Initiatives
- 8.9.3. Mental Mojo, LLC
- 8.9.3.1. Company Overview
- 8.9.3.2. Financial Performance
- 8.9.3.3. Product Benchmarking
- 8.9.3.4. Strategic Initiatives
- 8.9.4. NooCube
- 8.9.4.1. Company Overview
- 8.9.4.2. Financial Performance
- 8.9.4.3. Product Benchmarking
- 8.9.4.4. Strategic Initiatives
- 8.9.5. Mind Lab Pro (Performance Lab Group Ltd)
- 8.9.5.1. Company Overview
- 8.9.5.2. Financial Performance
- 8.9.5.3. Product Benchmarking
- 8.9.5.4. Strategic Initiatives
- 8.9.6. TruBrain
- 8.9.6.1. Company Overview
- 8.9.6.2. Financial Performance
- 8.9.6.3. Product Benchmarking
- 8.9.6.4. Strategic Initiatives
- 8.9.7. Neu Mind, LLC
- 8.9.7.1. Company Overview
- 8.9.7.2. Financial Performance
- 8.9.7.3. Product Benchmarking
- 8.9.7.4. Strategic Initiatives
- 8.9.8. Nooflux LLC
- 8.9.8.1. Company Overview
- 8.9.8.2. Financial Performance
- 8.9.8.3. Product Benchmarking
- 8.9.8.4. Strategic Initiatives
- 8.9.9. Zhou Nutrition
- 8.9.9.1. Company Overview
- 8.9.9.2. Financial Performance
- 8.9.9.3. Product Benchmarking
- 8.9.9.4. Strategic Initiatives
- 8.9.10. Kimera Koffee
- 8.9.10.1. Company Overview
- 8.9.10.2. Financial Performance
- 8.9.10.3. Product Benchmarking
- 8.9.10.4. Strategic Initiatives
- 8.9.1. Onnit Labs, Inc.
